NovaVision’s Vision Restoration Therapy, or VRT, is a restoration therapy specifically developed for patients who suffer from a visual field deficit resulting from a neurological trauma such as stroke or traumatic brain injury (TBI). VRT is a prescription therapy undertaken in the comfort of a patient’s own home, clinically supported by more than 15 years of research and 20 studies with FDA 510(k) clearance to be marketed in the US
While other rehabilitation modalities such as speech, physical and occupational therapy have been considered a standard of care for stroke and traumatic brain injury, NovaVision Vision Restoration Therapy addresses a previously unmet need for vision rehabilitation. Unlike other rehabilitation approaches that help patients compensate for their vision loss, VRT is developed to increase the sensitivity within the blind areas. Patients normally undergo VRT for six months, during which time they perform twice daily sessions six days per week, focusing and responding to light stimuli. Recent studies indicate that the mechanisms for recovery is based on neuroplasticity, the brain’s ability to adapt and form new connections or strengthen the pre-existing alternative pathways to overcome injury.